AlphaCrest Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $1.01M | Sell |
|
|||||
|
2022
Q2 | $809K | Buy |
|
|||||
|
2022
Q1 | $614K | Buy |
|
|||||
|
2021
Q4 | $473K | Sell |
|
|||||
|
2021
Q3 | $927K | Buy |
|
|||||
|
2021
Q2 | $447K | Sell |
|
|||||
|
2021
Q1 | $414K | Sell |
|
|||||
|
2020
Q4 | $1.09M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $210K | Sell |
|
|||||
|
2020
Q1 | $349K | Sell |
|
|||||
|
2019
Q4 | $899K | Sell |
|
|||||
|
2019
Q3 | $2.12M | Buy |
|